Drug profile · INN
ustekinumab
UPSTELDA
- US status
- approved
- Patents linked
- 0
- News articles
- 2
Quick answer
ustekinumab (UPSTELDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Related news
FDA Approves Stelara: New Ulcerative Colitis Treatment from J&J
Stelara, recently approved by the FDA, provides a new treatment option for ulcerative colitis, promising improved outcomes for patients.
FDA Approves First Interchangeable Biosimilar for Stelara (Ustekinumab)
The FDA has approved the first interchangeable biosimilar for Stelara (Ustekinumab), expanding treatment options for patients with psoriasis and Crohn's disease.
Frequently asked questions
What is ustekinumab?
ustekinumab (UPSTELDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ustekinumab?
UPSTELDA is a marketed brand name for ustekinumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ustekinumab?
ustekinumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.